Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jihwan Yun

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Scientific Reports|November 29, 2025
Computed tomography-based nnU-Net for region-specific brain structural changes across the alzheimer's continuum and frontotemporal dementia subtypesSeongbeom Park, Kyoungmin Kim, Kyoung Yoon Lim, et al.
Alzheimer'S Research & Therapy|April 25, 2024
Effects of risk factors on the development and mortality of early- and late-onset dementia: an 11-year longitudinal nationwide population-based cohort study in South KoreaMin Young Chun, Wonjeong Chae, Sang Won Seo, et al.
Frontiers in Aging Neuroscience|November 14, 2024
Association between focal amyloid deposition and cognitive impairment in individuals below the amyloid thresholdHongki Ham, Byeong C Kim, Eun Hye Lee, et al.
Dementia and Neurocognitive Disorders|May 5, 2025
Reproducibility of Plasma Biomarker Measurements Across Laboratories: Insights Into ptau217, GFAP, and NfLHeekyoung Kang, Sook-Young Woo, Daeun Shin, et al.
Scientific Reports|February 27, 2025
Comparison of accumulation rates of beta-amyloid tracers and their relationship with cognitive changesSoo Hyun Cho, Heekyoung Kang, Hongki Ham, et al.
JAMA Network Open|May 9, 2025
Cerebral Amyloid Angiopathy and Downstream Alzheimer Disease Plasma BiomarkersSung Hoon Kang, Eun Hye Lee, Young Ju Kim, et al.
Alzheimer'S Research & Therapy|May 22, 2026
Longitudinal plasma p-tau217 as a marker for tracking progression and predicting cognitive decline in Alzheimer's diseaseJehyun Ahn, Jihwan Yun, Michael W Weiner, et al.
Clinical Nuclear Medicine|October 10, 2024
Distinct Cognitive Trajectories According to Amyloid Positivity in Non-Alzheimer Disease DementiasHyemin Jang, Min Young Chun, Jihwan Yun, et al.
Scientific Reports|August 21, 2025
Mapping Alzheimer's disease pathology using free water through integrated analysis of plasma biomarkers, microstructural DTI metrics, and macrostructural MRI measuresBo-Hyun Kim, Daeun Shin, Sung Hoon Kang, et al.
Alzheimer'S Research & Therapy|August 29, 2024
Different associations between body mass index and Alzheimer's markers depending on metabolic healthEun Hye Lee, Heejin Yoo, Young Ju Kim, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Scientific Reports|November 29, 2025
Computed tomography-based nnU-Net for region-specific brain structural changes across the alzheimer's continuum and frontotemporal dementia subtypesSeongbeom Park, Kyoungmin Kim, Kyoung Yoon Lim, et al.
Alzheimer'S Research & Therapy|April 25, 2024
Effects of risk factors on the development and mortality of early- and late-onset dementia: an 11-year longitudinal nationwide population-based cohort study in South KoreaMin Young Chun, Wonjeong Chae, Sang Won Seo, et al.
Frontiers in Aging Neuroscience|November 14, 2024
Association between focal amyloid deposition and cognitive impairment in individuals below the amyloid thresholdHongki Ham, Byeong C Kim, Eun Hye Lee, et al.
Dementia and Neurocognitive Disorders|May 5, 2025
Reproducibility of Plasma Biomarker Measurements Across Laboratories: Insights Into ptau217, GFAP, and NfLHeekyoung Kang, Sook-Young Woo, Daeun Shin, et al.
Scientific Reports|February 27, 2025
Comparison of accumulation rates of beta-amyloid tracers and their relationship with cognitive changesSoo Hyun Cho, Heekyoung Kang, Hongki Ham, et al.
JAMA Network Open|May 9, 2025
Cerebral Amyloid Angiopathy and Downstream Alzheimer Disease Plasma BiomarkersSung Hoon Kang, Eun Hye Lee, Young Ju Kim, et al.
Alzheimer'S Research & Therapy|May 22, 2026
Longitudinal plasma p-tau217 as a marker for tracking progression and predicting cognitive decline in Alzheimer's diseaseJehyun Ahn, Jihwan Yun, Michael W Weiner, et al.
Clinical Nuclear Medicine|October 10, 2024
Distinct Cognitive Trajectories According to Amyloid Positivity in Non-Alzheimer Disease DementiasHyemin Jang, Min Young Chun, Jihwan Yun, et al.
Scientific Reports|August 21, 2025
Mapping Alzheimer's disease pathology using free water through integrated analysis of plasma biomarkers, microstructural DTI metrics, and macrostructural MRI measuresBo-Hyun Kim, Daeun Shin, Sung Hoon Kang, et al.
Alzheimer'S Research & Therapy|August 29, 2024
Different associations between body mass index and Alzheimer's markers depending on metabolic healthEun Hye Lee, Heejin Yoo, Young Ju Kim, et al.
Pageof 4